Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
Investigating the interactions between Aspergillus fumigatus and mast cells during chronic pulmonary fungal colonization.
EF 2013-14
Résumé
Aspergillus fumigatus (AF) is a ubiquitous mold, whose spores we inhale by the hundreds every day. In healthy individuals, these spores are cleared by the immune cells of the lung, and no disease results. However, in patients with underlying lung disease, the spores evade killing and grow into filamentous forms called hyphae that grow within the airways. A minority (<5%) of these patients will develop a severe form of allergic asthma triggered by the fungus known as allergic bronchopulmonary aspergillosis (ABPA). Although the majority of patients will not develop this allergy, the presence of AF in the lungs is nonetheless associated with a significant decline in lung function and an increased rate of hospitalizations.
The underlying mechanisms behind these non-allergic responses remain unknown. However, recent studies from the Sheppard laboratory have found that AF directly induces the stimulation of a type of immune cell, called mast cells, leading to the release of substances that promote lung injury and inflammation. I have found that in a mouse model of AF lung disease that the presence of mast cells actually promotes fungal growth. Further, I have identified a molecule on the fungal surface, galactosaminogalactan, and a corresponding molecule on mast cells, termed galectin-3, that I hypothesize are responsible for mast cell stimulation. I will test this hypothesis using a newly developed mouse model of AF chronic airway colonization.
This study will define the role of mast cells during the course of AF infection for the first time, and help us to understand the events underlying fungal growth in damaged lungs. I believe these experiments will ultimately lead to the identification of new therapeutics to improve the lives of those patients affected by this disease.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
307841
Name
Snarr Brendan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the interactions between Aspergillus fumigatus and mast cells during chronic pulmonary fungal colonization.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Aspergillus Fumigatus; Binding Kinetics; Carbohydrate Recognition; Cyto/Chemokine; Mouse Model; Pulmonary Mast Cells; Transgenic Knock-Out
Abstract
Aspergillus fumigatus (AF) is a ubiquitous mold, whose spores we inhale by the hundreds every day. In healthy individuals, these spores are cleared by the immune cells of the lung, and no disease results. However, in patients with underlying lung disease, the spores evade killing and grow into filamentous forms called hyphae that grow within the airways. A minority (<5%) of these patients will develop a severe form of allergic asthma triggered by the fungus known as allergic bronchopulmonary aspergillosis (ABPA). Although the majority of patients will not develop this allergy, the presence of AF in the lungs is nonetheless associated with a significant decline in lung function and an increased rate of hospitalizations.
The underlying mechanisms behind these non-allergic responses remain unknown. However, recent studies from the Sheppard laboratory have found that AF directly induces the stimulation of a type of immune cell, called mast cells, leading to the release of substances that promote lung injury and inflammation. I have found that in a mouse model of AF lung disease that the presence of mast cells actually promotes fungal growth. Further, I have identified a molecule on the fungal surface, galactosaminogalactan, and a corresponding molecule on mast cells, termed galectin-3, that I hypothesize are responsible for mast cell stimulation. I will test this hypothesis using a newly developed mouse model of AF chronic airway colonization.
This study will define the role of mast cells during the course of AF infection for the first time, and help us to understand the events underlying fungal growth in damaged lungs. I believe these experiments will ultimately lead to the identification of new therapeutics to improve the lives of those patients affected by this disease.
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Snarr, Brendan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~